PATENT CLAIM ANALYSIS

Application Number: 15777700
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "679000"]

Abstract:
The combination of curcumin and resveratrol can prevent the microglia from participating in the inflammation pathway in the brain. Thus this combination can reduce/prevent inflammation in the brain secondary to conditions such as obesity, diabetes, injury, and infection. The combination can also reduce chronic pain.

Claim (Index 2):
A method according to  claim 1  wherein the resveratrol and curcumin is administered at a dose of 1-1000 mg per day.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 93.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11789583', '14449599', '11478073', '15499440', '13912844']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6823477067534928
- 35 USC 102 Novelty (BERT): 0.4842776491909586
- Combined Prediction Score: 0.6625407009972394
- Mean Citation Score: 166.35254
- Max Citation Score: 172.91593999999995
- Similarity Product: 123.00578842400309

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test